CAPS — Capstone Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Capstone Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2015 December 31st	2016 December 31st	2017 December 31st	2018 December 31st	2019 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.01	0.698	1.27	1.34	0.058
Total Other Current Assets
Total Current Assets	1.26	0.829	1.37	1.44	0.284
Net Property, Plant And Equipment	0	0	0	—	0
Net Intangible Assets
Total Assets	1.77	1.18	1.57	1.48	0.284
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	0.261	0.304	0.199	0.246	1.16
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	1.26	1.3	2.45	2.72	3.58
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.506	-0.122	-0.879	-1.24	-3.3
Total Liabilities & Shareholders' Equity	1.77	1.18	1.57	1.48	0.284
Total Common Shares Outstanding